
The impact of noise induced by drilling on hearing during ear operations has been discussed several times in the past. However, direct measurements of the equivalent sound pressure level in patients undergoing ear surgery have not previously been reported. This pilot study presents an easy-to-use method based on a calibrated accelerometer to determine the equivalent sound pressure level potentially applicable in the clinical routine. During seven monitored cochlear implant surgeries, the equivalent A-weighted sound pressure level LAF ranged from 111 to 126 dB(A)eqSPL at its maximum, whereas C-weighted peak levels LCpeak showed peaks up to 140 dB(C)eqSPL. The recommended daily noise exposure limit was exceeded for three of the seven patients, suggesting the potential for drilling-induced temporal shifts in hearing threshold. Based on these findings, standardized noise monitoring is recommended as a quality assurance measure during otological surgery.
The biomedical technology requires compact and wideband wearable antennas to ensure reliable wireless transmission of physiological large data for continuous health monitoring and biomedical telemetry. To meet these requirements, a unique modified hexagonal radiator incorporated with slots and stub which perturb the current paths to offer multiple resonances. Together, these frequencies combined to form wideband behavior from 1.95 to 7.45 GHz that includes 5G band and ISM band range which is appropriate for biomedical applications. EVA foam is utilized as the substrate in the proposed antenna for wearer comfort and flexibility, which has an antenna dimension of 48 × 36 × 1.7 mm3. The wideband operation over the frequency achieves a fractional bandwidth of 117
Local ablation is a cornerstone of hepatocellular carcinoma management. However, thermal techniques are unsuitable for perivascular tumors due to the heat-sink effect and risk of injury to adjacent critical structures. While non-thermal pulsedfield ablation (PFA) overcomes these limitations, its percutaneous needle-based delivery risks tract seeding and potential vascular injury. This study evaluates a novel transvascular PFA approach using intravascularly delivered electrodes. By circumventing percutaneous needle-based electrode insertion, this strategy may reduce puncture-related complications and enable the ablation of tumors adjacent to major vessels. A custom endovascular PFA electrode was developed. Candidate treatment parameters were selected based on computational modeling. Subsequent transvascular PFA was performed in healthy rabbits with electrodes in the portal vein and inferior vena cava, assessing safety and histology over 28 days. The feasibility of tumor ablation was then evaluated in a rabbit VX2 orthotopic liver tumor model. Based on simulations, a protocol of 800 V (corresponding to an electric field strength of 1000 V/cm across the 8-mm electrode gap) and 80 pulses was selected, at which the modeled field between electrodes exceeded a conservative irreversible electroporation threshold (600 V/cm) without predictive thermal injury. In vivo, the procedure caused no persistent alterations in vital signs. Histopathological analysis showed coagulative necrosis of the targeted liver parenchyma and extensive necrosis of VX2 tumor tissue within the ablation zone, followed by a characteristic inflammatory and fibrotic repair response. Although the perivascular parenchyma was ablated, the structural architecture of the portal vein and inferior vena cava was preserved. Re-endothelialization was evident by day 21. Apart from a transient surgery-related fibrinogen elevation, coagulation parameters showed no PFA-specific changes under perioperative anticoagulant and postoperative antiplatelet therapy. No vascular perforation, acute occlusion, or ablation-related hemorrhage occurred in any animal. Transvascular PFA achieved effective ablation of liver tissue and transplanted VX2 liver tumors adjacent to major vessels while preserving vascular architecture, without evidence of significant thermal injury and major vascular injury-related complication. These preliminary findings suggest that transvascular PFA is promising and innovative, yet further investigation is warranted for high-risk anatomical tumors.
Electroporation produces reversible or irreversible plasma membrane permeabilization depending on pulse parameters and biological context. However, direct comparisons of membrane and organelle ultrastructure after reversible electroporation (RE) and irreversible electroporation (IRE) remain limited. This study characterized their multilevel structural effects in tumor cells and porcine tissues. KPC pancreatic cancer cells and Hepa1-6 hepatocellular carcinoma cells were treated with 60 pulses of 90 μs at 750 V/cm (operational RE) or 1,250 V/cm (operational IRE). Transmission electron microscopy (TEM) was used to examine mitochondrial and endoplasmic reticulum morphology, whereas scanning electron microscopy (SEM) and free-fluorescein isothiocyanate uptake were used to assess cell surface morphology and membrane permeability. Candidate nanopores were operationally identified using control-derived diameter thresholds and analyzed by Gaussian mixture modeling. Porcine liver and pancreas from animals were examined 24 h after IRE. RE was associated with mitochondrial contraction, increased matrix density, reduced cristae, and limited endoplasmic reticulum dilation. IRE caused extensive mitochondrial and endoplasmic reticulum swelling, cristae disruption, membrane fragmentation, increased FITC uptake, and numerous membrane surface depressions. IRE shifted the median depression diameter from 28 to 48 nm in KPC cells and from 30 to 111 nm in Hepa1-6 cells (Holm-adjusted P < 0.001). Candidate-nanopore diameters showed cell line-specific non-unimodal distributions, with fitted components centered at approximately 91 and 262 nm in KPC cells and 101, 199, and 369 nm in Hepa1-6 cells. Related tissue surface alterations and pore-like erythrocyte membrane discontinuities were observed in porcine liver and pancreas. Microsecond electroporation produced a graded ultrastructural response, ranging from limited organelle alterations after RE to extensive membrane and organelle disruption after IRE. These findings establish a structural framework for future mechanistic studies and pulse-parameter optimization.
Deep learning-based radiotherapy dose prediction has the potential to support automated treatment planning and plan-quality assessment; however, simultaneous integrated boost (SIB) volumetric modulated arc therapy (VMAT) for esophageal cancer remains challenging because multiple target levels are associated with different prescription doses and complex spatial relationships. We developed a prescription-aware diffusion Transformer framework for esophageal VMAT dose prediction and evaluated voxel-wise prediction accuracy, prescription-specific target behavior, and target-integrity sensitivity in a dual-center cohort. The global MAE within the body/union PTV MAE of DoseDiT was 3.15/4.79 Gy in the validation set, 3.07/4.99 Gy in the internal test set, and 4.25/7.47 Gy in the external test set. Target-level analysis revealed a systematic prescription-dependent bias, characterized primarily by persistent underestimation of D95/Rx for Boost targets in both the internal and external cohorts. After RxMap ablation, the PTV MAE increased to 5.35 Gy internally and 8.17 Gy externally, supporting the value of voxel-wise prescription representation for modeling complex target-dose distributions. GlobalPSDM provided no additional accuracy gain, whereas the MMFNet baseline under matched settings achieved lower errors. These findings indicate that the principal value of this study lies in prescription-aware representation and target-level error characterization. The voxel-wise RxMap provides local prescription-level information for SIB treatment plans, with its contribution concentrated primarily within target regions. Target-level analysis further demonstrated a systematic prescription-dependent coverage bias, with underestimation of Boost coverage showing good reproducibility in both the internal and external cohorts. GlobalPSDM did not provide an additional prediction-accuracy gain in the current implementation, whereas the matched MMFNet baseline achieved lower values for the major error metrics. These findings indicate that heterogeneous-prescription dose prediction should consider local prescription representation, target-level evaluation, and cross-center model robustness simultaneously. The current DoseDiT can serve as a research-oriented dose prior and analytical framework; further clinical translation will require three-dimensional or physics-aware modeling and prospective multicenter validation.